DE1077677T1 - Biologisch aktive zusammensetzung - Google Patents

Biologisch aktive zusammensetzung

Info

Publication number
DE1077677T1
DE1077677T1 DE1077677T DE99927062T DE1077677T1 DE 1077677 T1 DE1077677 T1 DE 1077677T1 DE 1077677 T DE1077677 T DE 1077677T DE 99927062 T DE99927062 T DE 99927062T DE 1077677 T1 DE1077677 T1 DE 1077677T1
Authority
DE
Germany
Prior art keywords
biologically active
active agent
carrier
chemical operation
active composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1077677T
Other languages
English (en)
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglan AB
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of DE1077677T1 publication Critical patent/DE1077677T1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE1077677T 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung Pending DE1077677T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (1)

Publication Number Publication Date
DE1077677T1 true DE1077677T1 (de) 2001-09-20

Family

ID=20411319

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1077677T Pending DE1077677T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
DE69912271T Expired - Lifetime DE69912271T2 (de) 1998-05-14 1999-05-12 Verfahren zur Herstellung einer biologisch wirksamen Zusammensetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69912271T Expired - Lifetime DE69912271T2 (de) 1998-05-14 1999-05-12 Verfahren zur Herstellung einer biologisch wirksamen Zusammensetzung

Country Status (20)

Country Link
EP (1) EP1077677B1 (de)
JP (1) JP2002514588A (de)
KR (1) KR100766998B1 (de)
CN (1) CN1309554A (de)
AT (1) ATE252371T1 (de)
AU (1) AU742921B2 (de)
CA (1) CA2332110A1 (de)
DE (2) DE1077677T1 (de)
DK (1) DK1077677T3 (de)
ES (1) ES2155049T3 (de)
GR (1) GR20010300014T1 (de)
HU (1) HUP0102002A3 (de)
IL (2) IL139577A0 (de)
NO (1) NO20005725L (de)
NZ (1) NZ508074A (de)
PL (1) PL344221A1 (de)
SE (1) SE9801705D0 (de)
TR (1) TR200003588T2 (de)
WO (1) WO1999058109A1 (de)
ZA (1) ZA200006476B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
KR20060095863A (ko) * 2003-08-06 2006-09-04 니르말 뮬레 수용성 의약을 함유하는 제약학적 조성물
CA2653782A1 (en) 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
WO2012028496A1 (de) * 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
KR20140089478A (ko) * 2011-01-13 2014-07-15 큐엘티 인코포레이티드 감광제의 국소 전달용 약학 조성물 및 그의 이용

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
AU742921B2 (en) 2002-01-17
DK1077677T3 (da) 2004-02-16
WO1999058109A1 (en) 1999-11-18
KR20010052349A (ko) 2001-06-25
DE69912271T2 (de) 2004-08-26
ATE252371T1 (de) 2003-11-15
IL139577A0 (en) 2002-02-10
DE69912271D1 (de) 2003-11-27
EP1077677A1 (de) 2001-02-28
NO20005725L (no) 2001-01-11
ES2155049T3 (es) 2004-05-16
IL139577A (en) 2007-07-04
AU4405199A (en) 1999-11-29
PL344221A1 (en) 2001-10-08
CN1309554A (zh) 2001-08-22
ES2155049T1 (es) 2001-05-01
CA2332110A1 (en) 1999-11-18
SE9801705D0 (sv) 1998-05-14
HUP0102002A3 (en) 2002-12-28
ZA200006476B (en) 2001-06-11
NO20005725D0 (no) 2000-11-13
KR100766998B1 (ko) 2007-10-15
EP1077677B1 (de) 2003-10-22
NZ508074A (en) 2003-01-31
HUP0102002A2 (hu) 2002-03-28
JP2002514588A (ja) 2002-05-21
GR20010300014T1 (en) 2001-04-30
TR200003588T2 (tr) 2001-06-21

Similar Documents

Publication Publication Date Title
ES2118677T1 (es) Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion.
TR199900353T2 (xx) Kontroll� salma sa�layan cihazlar�n yap�m� i�in y�ntem.
NO954957L (no) Synergistisk stabiliserte flytende enzymatiske blandinger
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
SE9801705D0 (sv) Biologically active composition
ATE310500T1 (de) Biologisch aktive zusammensetzung
MD1360C2 (ro) Compoziţie fungicidă, procedeu de combatere şi prevenire a infectării cu Oomicete a plantelor
ATE290387T1 (de) Ribavirin-granulat zur herstellung von filmtabletten
KR900001830A (ko) 트리폴리포스페이트를 함유하는 액상 세제의 제조방법
SU1820809A1 (ru) Лазерное вещество
JPS57136503A (en) Expellent for noxious mollusk
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
KR910002492A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
KR830007470A (ko) 활성무기 식물영양제(活性無機植物營養劑)
TH48057A3 (th) สารผสมที่จะเพิ่มการยอมให้ผ่านของตัวกระทำเฉพาะที่ผิวหนัง
KR870006867A (ko) 담뱃불 소화 혼합물체 제조방법
TH1086A (th) ส่วนประกอบสารทำให้ผ้านุ่ม